Experimental COVID-19 drug passes early safety check in small trial
Disease control
Completed
This early-stage study tested a new drug called SIR1-365 in 45 hospitalized adults with severe COVID-19. The main goal was to see if the drug is safe and tolerable. Researchers also looked at whether it could reduce inflammation and improve patient outcomes. The trial was complet…
Phase: PHASE1 • Sponsor: Sironax USA, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC